FFilingLens
← Back to search
BI

BIOGEN INC.

BIIB Health Care · Pharmaceuticals & Biotechnology
Latest period 2026-06-30 · 38 filings on record
Quarterly TTM Annual
3Y 5Y 8FY 10Y MAX
FY 2009 → FY 2025 17 YEARS
SHOWING Fiscal years as the company filed them — each point is one closed year from its 10-K, ending on that year's own close. A year with no 10-K on file is assembled from its four quarters and labelled by its ending date instead; a year still open gets no column at all.
Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.

Growth 4th pct

▼−9 over range · as of 2025-12-31

Quality 29th pct

▼−3 over range · as of 2025-12-31

Safety 77th pct

▲+10 over range · as of 2025-12-31

OVERVIEWYoY Δ

Latest fiscal year · ending 2025-12-31 · green = improving · click a row to chart it

Revenue $9.9B +2.2% Gross margin 75.7% −0.4pp Operating margin — — Net margin 13.1% −3.8pp Net income $1.3B −20.8%
Debt / equity 0.34 −28.4%
EPS (diluted) $8.79 −21.4% EBITDA — —

Filings

Full history 38 match
ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓
Year Q1Q2Q3FY
2026 10-Q
2025 10-Q 10-Q 10-Q 10-K
2024 10-Q 10-Q 10-Q 10-K
2023 10-Q 10-Q 10-Q 10-K
2022 10-Q 10-Q 10-K
2021 10-Q 10-Q 10-Q 10-K
2020 10-Q 10-Q 10-Q 10-K
2019 10-Q 10-K
10-Q — 2026-07-29 Pro → 10-Q Q1 2026 2026-04-29 Pro → 10-K FY 2025 2026-02-06 Pro → 10-Q Q3 2025 2025-10-30 Pro → 10-Q Q2 2025 2025-07-31 Pro → 10-Q Q1 2025 2025-05-01 Pro →
All 38 filings 10-K FY 2024 2025-02-12 Pro → 10-Q Q3 2024 2024-10-30 Pro → 10-Q Q2 2024 2024-08-01 Pro → 10-Q Q1 2024 2024-04-24 Pro → 10-K FY 2023 2024-02-14 Pro → 10-Q Q3 2023 2023-11-08 Pro → 10-Q Q2 2023 2023-07-25 Pro → 10-Q Q1 2023 2023-04-25 Pro → 10-K FY 2022 2023-02-15 Pro → 10-Q Q3 2022 2022-10-25 Pro → 10-Q Q1 2022 2022-07-20 Pro → 10-Q Q1 2022 2022-05-03 Pro → 10-K FY 2021 2022-02-03 Pro → 10-Q Q3 2021 2021-10-20 Pro → 10-Q Q2 2021 2021-07-22 Pro → 10-Q Q1 2021 2021-04-22 Pro → 10-K FY 2020 2021-02-03 Pro → 10-Q Q3 2020 2020-10-21 Pro → 10-Q Q2 2020 2020-07-22 Pro → 10-Q Q1 2020 2020-04-23 Pro → 10-K FY 2019 2020-02-06 Pro → 10-Q Q3 2019 2019-10-22 Pro → 10-K FY 2018 2019-02-06 Pro → 10-K FY 2017 2018-02-01 Pro → 10-K FY 2016 2017-02-02 Pro → 10-K FY 2015 2016-02-03 Pro → 10-K FY 2014 2015-02-04 Pro → 10-K FY 2013 2014-02-06 Pro → 10-K FY 2012 2013-02-05 Pro → 10-K FY 2011 2012-02-03 Pro → 10-K FY 2010 2011-02-04 Pro → 10-K FY 2009 2010-02-09 Pro →

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Fiscal years as the company filed them
Revenue
Latest$9.9B YoY+2.2% Periods17
$14.4B$9.5B$4.7B$0FY 20092009-12-31FY 20172017-12-31FY 20252025-12-31
Revenue by period
PeriodPeriod end Revenue
FY 20092009-12-31 $4.4B
FY 20102010-12-31 $4.7B
FY 20112011-12-31 $5.0B
FY 20122012-12-31 $5.5B
FY 20132013-12-31 $6.9B
FY 20142014-12-31 $9.7B
FY 20152015-12-31 $10.8B
FY 20162016-12-31 $11.4B
FY 20172017-12-31 $12.3B
FY 20182018-12-31 $13.5B
FY 20192019-12-31 $14.4B
FY 20202020-12-31 $13.4B
FY 20212021-12-31 $11.0B
FY 20222022-12-31 $10.2B
FY 20232023-12-31 $9.8B
FY 20242024-12-31 $9.7B
FY 20252025-12-31 $9.9B
Net income
Latest$1.3B YoY−20.8% Periods17
$5.9B$3.9B$1.9B$0FY 20092009-12-31FY 20172017-12-31FY 20252025-12-31
Net income by period
PeriodPeriod end Net income
FY 20092009-12-31 $970.1M
FY 20102010-12-31 $1.0B
FY 20112011-12-31 $1.2B
FY 20122012-12-31 $1.4B
FY 20132013-12-31 $1.9B
FY 20142014-12-31 $2.9B
FY 20152015-12-31 $3.5B
FY 20162016-12-31 $3.7B
FY 20172017-12-31 $2.5B
FY 20182018-12-31 $4.4B
FY 20192019-12-31 $5.9B
FY 20202020-12-31 $4.0B
FY 20212021-12-31 $1.6B
FY 20222022-12-31 $3.0B
FY 20232023-12-31 $1.2B
FY 20242024-12-31 $1.6B
FY 20252025-12-31 $1.3B
Operating income
Latest— YoY— Periods13
$7.0B$4.6B$2.3B$0FY 20092009-12-31FY 20172017-12-31FY 20252025-12-31
Operating income by period
PeriodPeriod end Operating income
FY 20092009-12-31 $1.3B
FY 20102010-12-31 $1.2B
FY 20112011-12-31 $1.7B
FY 20122012-12-31 $1.9B
FY 20132013-12-31 $2.5B
FY 20142014-12-31 $4.0B
FY 20152015-12-31 $4.9B
FY 20162016-12-31 $5.2B
FY 20172017-12-31 $5.3B
FY 20182018-12-31 $5.9B
FY 20192019-12-31 $7.0B
FY 20202020-12-31 $4.6B
FY 20212021-12-31 $2.8B
FY 20222022-12-31 not reported
FY 20232023-12-31 not reported
FY 20242024-12-31 not reported
FY 20252025-12-31 not reported
ZOOM
FY 2009 FY 2025

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 4 Quality 29 Safety 77
0255075100FY 20092009-12-31FY 20172017-12-31FY 20252025-12-31

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
PeriodPeriod end GrowthQualitySafety
FY 20092009-12-31 not scorednot scorednot scored
FY 20102010-12-31 not scorednot scorednot scored
FY 20112011-12-31 not scorednot scorednot scored
FY 20122012-12-31 not scorednot scorednot scored
FY 20132013-12-31 not scorednot scorednot scored
FY 20142014-12-31 not scorednot scorednot scored
FY 20152015-12-31 not scorednot scorednot scored
FY 20162016-12-31 not scorednot scorednot scored
FY 20172017-12-31 not scorednot scorednot scored
FY 20182018-12-31 not scorednot scorednot scored
FY 20192019-12-31 not scorednot scorednot scored
FY 20202020-12-31 not scorednot scorednot scored
FY 20212021-12-31 not scorednot scorednot scored
FY 20222022-12-31 not scorednot scorednot scored
FY 20232023-12-31 133267
FY 20242024-12-31 384949
FY 20252025-12-31 42977